Get a perspective from patients with CML
Clinical Considerations and Treatment Challenges
See what patients have to say about their experience with CML treatment, including challenges they faced, how they overcame them, and the potential clinical ramifications.
The Day-to-Day Impact of TKIs
See what patients have to say about how CML treatment can impact their daily life, as well as their thoughts about what makes a TKI a good fit for them.
Conversations in care
Hear what the experts have to say
Conversations in Care: Establishing Good Rapport
Ted Braun, MD, and Diana Brewer, PA-C, of the Oregon Health & Science University Knight Cancer Center, discuss how to manage a patient with CML on their 2nd TKI who may not be communicating their tolerability issues with their health care team.
How Do You Monitor TKI Tolerability Issues Among Patients Receiving TKIs?
Moshe Talpaz, MD, describes the importance of a strong team and early action for monitoring TKI tolerability issues among his patients receiving TKIs.
FAQ: Is Switching Due to Low-Grade AEs Appropriate?
Moshe Talpaz, MD, talks about the importance of considering low-grade AEs when it comes to treating patients in later lines of CML.
CML uncovered
Watch an informative series exploring common misperceptions in CML
CML Uncovered: Is CML Really Solved?
Despite advances in TKIs in the last 20 years, some patients still struggle with CML due to adverse events and intolerance. This video discusses how to potentially optimize treatment and move one step closer to solving CML for more patients.
CML Uncovered: Are Your Patients Holding Back?
This video discusses the various reasons why patients don’t always relate their true experiences with CML medications. Once aware of this communication gap, HCPs can make better assessments to help close the gap and potentially improve compliance.
Learn more about the challenges of CML treatment
AE, adverse event; CML, chronic myeloid leukemia; TKI, tyrosine kinase inhibitor.